{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:22:58Z","timestamp":1792664578947,"version":"4.5.0"},"reference-count":83,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Medical University of Lodz","award":["503\/1-152-01\/503-11-001"],"award-info":[{"award-number":["503\/1-152-01\/503-11-001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Psoriatic arthritis is a heterogenous chronic inflammatory disease that develops over time in some patients with psoriasis. The course of the disease is variable, with a broad clinical spectrum. The management of PsA has changed tremendously over the last decade, thanks to earlier diagnosis, a multidisciplinary approach and progress in pharmacological therapies. Therefore, screening for risk factors and the early signs of arthritis is highly important and recommended. Currently, research is focused on finding soluble biomarkers and developing imaging techniques that can improve the prediction of psoriatic arthritis. Among imaging modalities, ultrasonography seems to be the most accurate in detecting subclinical inflammation. Early intervention is based on the assumption that it is possible to prevent or delay psoriatic arthritis if systemic treatment for psoriasis can be administered early enough. This review article provides an overview of the current perspectives and evidence regarding the diagnosis, management and prevention of psoriatic arthritis.<\/jats:p>","DOI":"10.3390\/jcm12113850","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T02:18:29Z","timestamp":1685931509000},"page":"3850","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Psoriatic Arthritis: Development, Detection and Prevention: A Scoping Review"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-0867","authenticated-orcid":false,"given":"Agnieszka","family":"Kimak","sequence":"first","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Robak","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Makowska","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Medical University of Lodz, Zeromskiego 113, 90-549 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wo\u017aniacka","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Medical University of Lodz, Hallera 1, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jaad.2018.06.027","article-title":"Prevalence of psoriatic arthritis in patients with psoriasis: A systematic review and meta-analysis of observational and clinical studies","volume":"80","author":"Alinaghi","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/PTT.S323300","article-title":"Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis","volume":"12","author":"Gisondi","year":"2022","journal-title":"Psoriasis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_4","first-page":"1022","article-title":"Clinical and radiological changes during psoriatic arthritis disease progression","volume":"30","author":"Khan","year":"2003","journal-title":"J. Rheumatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/rheumatology\/keg217","article-title":"Progression of peripheral joint disease in psoriatic arthritis: A 5-yr prospective study","volume":"42","author":"McHugh","year":"2003","journal-title":"Rheumatology"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s11926-020-00891-x","article-title":"From Psoriasis to Psoriatic Arthritis: Insights from Imaging on the Transition to Psoriatic Arthritis and Implications for Arthritis Prevention","volume":"22","author":"Zabotti","year":"2020","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.jaad.2021.09.019","article-title":"Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States","volume":"86","author":"Merola","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1093\/rheumatology\/keab622","article-title":"Body surface area affected by psoriasis and the risk for psoriatic arthritis: A prospective population-based cohort study","volume":"61","author":"Ogdie","year":"2022","journal-title":"Rheumatology"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/art.24172","article-title":"Incidence and clinical predictors of psoriatic arthritis in patients with psoriasis: A population-based study","volume":"61","author":"Wilson","year":"2009","journal-title":"Arthritis Rheum."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jaad.2019.01.072","article-title":"Recommendations for the definition, evaluation, and treatment of nail psoriasis in adult patients with no or mild skin psoriasis: A dermatologist and nail expert group consensus","volume":"81","author":"Rigopoulos","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/acr.23836","article-title":"Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease","volume":"72","author":"Solmaz","year":"2020","journal-title":"Arthritis Care Res."},{"key":"ref_12","first-page":"361","article-title":"THU0285 The effect of family history on disease phenotypes in 1393 psoriatic arthritis patients","volume":"77","author":"Solmaz","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pollock, R.A., Zaman, L., Chandran, V., and Gladman, D.D. (2019). Epigenome-wide analysis of sperm cells identifies IL22 as a possible germ line risk locus for psoriatic arthritis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0212043"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"746145","DOI":"10.3389\/fcell.2021.746145","article-title":"DNA Methylation Patterns in CD8+ T Cells Discern Psoriasis From Psoriatic Arthritis and Correlate With Cutaneous Disease Activity","volume":"9","author":"Charras","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1136\/annrheumdis-2012-201299","article-title":"Obesity and the risk of psoriatic arthritis: A population-based study","volume":"71","author":"Love","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11926-006-0065-8","article-title":"Metabolic disorders in patients with psoriasis and psoriatic arthritis","volume":"8","author":"Mallbris","year":"2006","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3906\/sag-2011-235","article-title":"Autoimmunity in psoriatic arthritis: Pathophysiological and clinical aspects","volume":"51","author":"Emmungil","year":"2021","journal-title":"Turk. J. Med. Sci."},{"key":"ref_18","first-page":"29","article-title":"The Skin May Clear But the Arthritis Won\u2019t Disappear: Focusing on Concomitant and New-Onset Psoriatic Arthritis in a Daily Practice Cohort of Psoriasis Patients on Biologic Therapy","volume":"10","author":"Groenewoud","year":"2020","journal-title":"Psoriasis"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"723944","DOI":"10.3389\/fmed.2021.723944","article-title":"Early origins of psoriatic arthritis: Clinical, genetic and molecular biomarkers of progression from psoriasis to psoriatic arthritis","volume":"18","author":"Pennington","year":"2021","journal-title":"Front. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"4613","DOI":"10.1038\/s41467-018-06933-4","article-title":"Mechanical strain determines the site-specific localization of inflammation and tissue damage in arthritis","volume":"9","author":"Gaublomme","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.semarthrit.2018.06.001","article-title":"The association between occupational-related mechanical stress and radiographic damage in psoriatic arthritis","volume":"48","author":"Zhou","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2009.03363.x","article-title":"Enthesitis: An autoinflammatory lesion linking nail and joint involvement in psoriatic disease","volume":"23","author":"McGonagle","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/art.39973","article-title":"The Development of Psoriatic Arthritis in Patients With Psoriasis Is Preceded by a Period of Nonspecific Musculoskeletal Symptoms: A Prospective Cohort Study","volume":"69","author":"Eder","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3899\/jrheum.110845","article-title":"The ClASsification for Psoriatic ARthritis (CASPAR) criteria--a retrospective feasibility, sensitivity, and specificity study","volume":"39","author":"Tillett","year":"2012","journal-title":"J. Rheumatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1136\/annrheumdis-2012-201308","article-title":"Differential human leucocyte allele association between psoriasis and psoriatic arthritis: A family-based association study","volume":"71","author":"Eder","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.humimm.2013.07.014","article-title":"Human leukocyte antigen alleles and susceptibility to psoriatic arthritis","volume":"74","author":"Chandran","year":"2013","journal-title":"Hum. Immunol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00403-019-01902-3","article-title":"HLA-A*01:01 in MHC is associated with psoriatic arthritis in Chinese Han population","volume":"311","author":"Chen","year":"2019","journal-title":"Arch. Dermatol. Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1136\/ard.2010.143123","article-title":"Evidence to support IL-13 as a risk locus for psoriatic arthritis but not psoriasis vulgaris","volume":"70","author":"Bowes","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Butt, C., Lim, S., Greenwood, C., and Rahman, P. (2007). VEGF, FGF1, FGF2 and EGF gene polymorphisms and psoriatic arthritis. BMC Musculoskelet. Disord., 8.","DOI":"10.1186\/1471-2474-8-1"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.3389\/fimmu.2021.631603","article-title":"IL-33 gene polymorphisms as potential biomarkers of disease susceptibility and response to TNF inhibitors in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis patients","volume":"12","author":"Iwaszko","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00403-016-1706-z","article-title":"Investigation of 36 non-HLA (human leucocyte antigen) psoriasis susceptibility loci in a psoriatic arthritis cohort","volume":"309","author":"Zhang","year":"2017","journal-title":"Arch. Derm. Res."},{"key":"ref_32","first-page":"113","article-title":"Characterisation of peripheral blood mononuclear cell microRNA in early onset psoriatic arthritis","volume":"35","author":"Ciancio","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Lin, S.H., Ho, J.C., Li, S.C., Cheng, Y.W., Yang, Y.C., Chen, J.F., Hsu, C.Y., Nakano, T., Wang, F.S., and Yang, M.Y. (2020). Upregulation of miR-941 in Circulating CD14+ Monocytes Enhances Osteoclast Activation via WNT16 Inhibition in Patients with Psoriatic Arthritis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21124301"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/PTT.S328460","article-title":"Towards Personalized Medicine in Psoriasis: Current Progress","volume":"12","author":"Camela","year":"2022","journal-title":"Psoriasis"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2133\/dmpk.DMPK-12-RG-128","article-title":"Role of methotrexate polyglutamation and reduced folate carrier 1 (RFC1) gene polymorphisms in clinical assessment indexes","volume":"28","author":"Ando","year":"2013","journal-title":"Drug Metab. Pharmacokinet."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1038\/jid.2008.16","article-title":"Genetic variation in efflux transporters influences outcome to methotrexate therapy in patients with psoriasis","volume":"128","author":"Warren","year":"2008","journal-title":"J. Investig. Dermatol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00228-017-2255-x","article-title":"Pharmacogenetic markers to predict the clinical response to methotrexate in south Indian Tamil patients with psoriasis","volume":"73","author":"Indhumathi","year":"2017","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000514072","article-title":"The impact of ANxA6 gene polymorphism on the efficacy of methotrexate treatment in psoriasis patients","volume":"237","author":"Fan","year":"2021","journal-title":"Dermatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"13182","DOI":"10.1038\/s41598-018-31352-2","article-title":"Polymorphisms of SLCO1B1 rs4149056 and SLC22A1 rs2282143 are associated with responsiveness to Acitretin in psoriasis patients","volume":"8","author":"Chen","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/FPC.0000000000000218","article-title":"Val\/Val glutathione-S-transferase P1 polymorphism predicts nonresponders in psoriasis patients treated with fumaric acid esters","volume":"26","author":"Gambichler","year":"2016","journal-title":"Pharm. Genom."},{"key":"ref_41","first-page":"e271","article-title":"Polymorphisms associated with optimization of biological therapy through drug dose reduction in moderate-to-severe psoriasis","volume":"34","author":"Sabador","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"815121","DOI":"10.3389\/fimmu.2021.815121","article-title":"Genome-wide association study of ustekinumab response in psoriasis","volume":"12","author":"Connell","year":"2021","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1054539","DOI":"10.3389\/fimmu.2022.1054539","article-title":"Biomarkers in psoriatic arthritis: A meta-analysis and systematic review","volume":"13","author":"Wirth","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1136\/annrheumdis-2018-214737","article-title":"Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis","volume":"78","author":"Chandran","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.5114\/ada.2020.94903","article-title":"Interleukin-18, interleukin-20, and matrix metalloproteinases (MMP-1, MMP-3) as markers of psoriatic arthritis disease severity and their correlations with biomarkers of inflammation and turnover of joint cartilage","volume":"37","author":"Waszczykowski","year":"2020","journal-title":"Postep. Dermatol. I Alergol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Waszczykowski, M., Fabi\u015b-Strobin, A., Bednarski, I., Lesiak, A., Narbutt, J., and Fabi\u015b, J. (2020). Serum Biomarkers of Inflammation and Turnover of Joint Cartilage Can Help Differentiate Psoriatic Arthritis (PsA) Patients from Osteoarthritis (OA) Patients. Diagnostics, 11.","DOI":"10.3390\/diagnostics11010052"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.41652","article-title":"Tissue-resident memory CD8+ T cells from skin differentiate psoriatic arthritis from psoriasis","volume":"73","author":"Leijten","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jdermsci.2019.06.002","article-title":"Significance of IL-17A-producing CD8+ CD103+ skin resident memory T cells in psoriasis lesion and their possible relationship to clinical course","volume":"95","author":"Kurihara","year":"2019","journal-title":"J. Dermatol. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.4049\/jimmunol.1302313","article-title":"Epidermal Th22 and Tc17 cells form a localized disease memory in clinically healed psoriasis","volume":"192","author":"Cheuk","year":"2014","journal-title":"J. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"7","DOI":"10.12659\/PJR.883763","article-title":"Psoriatic arthritis","volume":"78","author":"Sankowski","year":"2013","journal-title":"Pol. J. Radiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2230.2007.02581.x","article-title":"Detection of subclinical joint involvement in psoriasis with bone scintigraphy and its response to oral methotrexate","volume":"33","author":"Raza","year":"2008","journal-title":"Clin. Exp. Derm."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/art.41239","article-title":"Association of Structural Entheseal Lesions With an Increased Risk of Progression From Psoriasis to Psoriatic Arthritis","volume":"74","author":"Simon","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1136\/annrheumdis-2015-208821","article-title":"Subclinical joint inflammation in patients with psoriasis without concomitant psoriatic arthritis: A cross-sectional and longitudinal analysis","volume":"75","author":"Faustini","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jcu.23170","article-title":"Psoriatic arthritis: Ultrasound peculiarities with particular emphasis on enthesitis","volume":"50","author":"Draghi","year":"2022","journal-title":"J. Clin. Ultrasound"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semarthrit.2017.12.008","article-title":"Enthesitis: A hallmark of psoriatic arthritis","volume":"48","author":"Kaeley","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"key":"ref_56","first-page":"593","article-title":"Ultrasonographic detection of subclinical enthesitis and synovitis: A possible stratification of psoriatic patients without clinical musculoskeletal involvement","volume":"37","author":"Zuliani","year":"2019","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"e001067","DOI":"10.1136\/rmdopen-2019-001067","article-title":"Transition phase towards psoriatic arthritis: Clinical and ultrasonographic characterisation of psoriatic arthralgia","volume":"5","author":"Zabotti","year":"2019","journal-title":"RMD Open"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s10067-019-04445-0","article-title":"Subclinical synovitis and enthesitis in psoriasis patients and controls by ultrasonography in Saudi Arabia; incidence of psoriatic arthritis during two years","volume":"38","author":"Elnady","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3899\/jrheum.170765","article-title":"Power doppler ultrasound evaluation of peripheral joint, entheses, tendon, and bursa abnormalities in psoriatic patients: A clinical study","volume":"45","author":"Tang","year":"2018","journal-title":"J. Rheumatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1136\/annrheumdis-2018-213025","article-title":"UPSTREAM study group. Ultrasonography in psoriatic arthritis: Which sites should we scan?","volume":"77","author":"Zabotti","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0042-1743116","article-title":"Role of Shear-Wave Elastography in Achilles Tendon in Psoriatic Arthritis and Its Correlation with Disease Severity Score, Psoriasis Area and Severity Index","volume":"32","author":"Saha","year":"2022","journal-title":"Indian J. Radiol. Imaging"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Krajewska-W\u0142odarczyk, M., and Owczarczyk-Saczonek, A. (2022). Usefulness of Ultrasound Examination in the Assessment of the Nail Apparatus in Psoriasis. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19095611"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Urruticoechea-Arana, A., Benavent, D., Le\u00f3n, F., Almodovar, R., Belinch\u00f3n, I., de la Cueva, P., Fern\u00e1ndez-Carballido, C., Loza, E., Gratac\u00f3s, J., and Cribado Working Group (2021). Psoriatic arthritis screening: A systematic literature review and experts\u2019 recommendations. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0248571"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1111\/jdv.14861","article-title":"Psoriatic arthritis screening by the dermatologist: Development and first validation of the \u2018PURE-4 scale\u2019","volume":"32","author":"Audureau","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1177\/12034754221128796","article-title":"Utilization of the Psoriasis Epidemiology Screening Tool (PEST): A Risk Stratification Strategy for Early Referral of Psoriatic Arthritis Patients to Minimize Irreversible Erosive Joint Damage","volume":"26","author":"Chang","year":"2022","journal-title":"J. Cutan. Med. Surg."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"adv00768","DOI":"10.2340\/actadv.v102.2225","article-title":"Discovery of Psoriatic Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER) Study: A Prospective Observational Cohort","volume":"102","author":"Mulder","year":"2022","journal-title":"Acta Derm.-Venereol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e31647","DOI":"10.2196\/31647","article-title":"Discovery of Arthritis in Psoriasis Patients for Early Rheumatological Referral (DAPPER): Protocol for a Longitudinal Observational Study","volume":"10","author":"Groenewoud","year":"2021","journal-title":"JMIR Res. Protoc."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/annrheumdis-2021-219961","article-title":"Biological disease-modifying antirheumatic drugs may mitigate the risk of psoriatic arthritis in patients with chronic plaque psoriasis","volume":"81","author":"Gisondi","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/annrheumdis-2021-220865","article-title":"Treating the skin with biologics in patients with psoriasis decreases the incidence of psoriatic arthritis","volume":"81","author":"LoGiudice","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/art.41946","article-title":"Incidence of Psoriatic Arthritis Among Patients Receiving Biologic Treatments for Psoriasis: A Nested Case-Control Study","volume":"74","author":"Rosenthal","year":"2022","journal-title":"Arthritis Rheumatol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"257","DOI":"10.55563\/clinexprheumatol\/8thj0l","article-title":"Evidence that systemic therapies for psoriasis may reduce psoriatic arthritis occurrence","volume":"38","author":"Solmaz","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.jbspin.2015.01.016","article-title":"Ultrasound study of entheses in psoriasis patients with or without musculoskeletal symptoms: A prospective study","volume":"82","author":"Acquacalda","year":"2015","journal-title":"Jt. Bone Spine"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13075-019-1957-0","article-title":"Disease interception with interleukin-17 inhibition in high-risk psoriasis patients with subclinical joint inflammation-data from the prospective IVEPSA study","volume":"21","author":"Kampylafka","year":"2019","journal-title":"Arthritis Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/art.40778","article-title":"Regression of Peripheral Subclinical Enthesopathy in Therapy-Naive Patients Treated With Ustekinumab for Moderate-to-Severe Chronic Plaque Psoriasis: A Fifty-Two-Week, Prospective, Open-Label Feasibility Study","volume":"71","author":"Savage","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"e063650","DOI":"10.1136\/bmjopen-2022-063650","article-title":"Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): Protocol of a randomised, double-blind, placebo controlled multicentre trial","volume":"12","author":"Haberman","year":"2022","journal-title":"BMJ Open"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1136\/annrheumdis-2021-220761","article-title":"Does biologic therapy impact the development of PsA among patients with psoriasis?","volume":"81","author":"Meer","year":"2022","journal-title":"Ann. Rheum. Dis."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jvc2.63","article-title":"Early intervention and disease memory in psoriasis: A literature review","volume":"1","author":"Emmanuel","year":"2022","journal-title":"JEADV Clin. Pract."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(08)60304-9","article-title":"Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn\u2019s disease: An open randomised trial","volume":"371","author":"Baert","year":"2008","journal-title":"Lancet"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(08)61000-4","article-title":"Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial","volume":"372","author":"Emery","year":"2008","journal-title":"Lancet"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1027347","DOI":"10.3389\/fmed.2022.1027347","article-title":"Early intervention in psoriasis: Where do we go from here?","volume":"9","author":"Felix","year":"2022","journal-title":"Front. Med."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1468-3083.2012.04605.x","article-title":"Is \u2018class effect\u2019 relevant when assessing the benefit\/risk profile of a biologic agent?","volume":"5","author":"Sterry","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"ref_82","first-page":"137","article-title":"Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: A combined dermatology and rheumatology clinical study","volume":"35","author":"Napolitano","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"ref_83","first-page":"733","article-title":"LUMEN study group. Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy","volume":"155","author":"Balato","year":"2020","journal-title":"Ital. J. Dermatol. Venereol."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/11\/3850\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:48:15Z","timestamp":1760125695000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/11\/3850"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":83,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["jcm12113850"],"URL":"https:\/\/doi.org\/10.3390\/jcm12113850","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]}}}